Nunes Anne has filed 25 insider transactions across 1 company since October 2023.
Most recent transaction: a option exercise of 3637 shares of Anika Therapeutics, Inc. ($ANIK) on March 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 3637 | $0.00 | 21,722.0000 | 14,721,000 | 20.11% | 0.02% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 1068 | $15.91 | 20,654.0000 | 14,721,000 | 4.92% | 0.01% |
| March 14, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | A | Restricted Stock Unit | 20761 | $0.00 | 20,761.0000 | 14,721,000 | 9999.99% | 0.14% |
| March 14, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | A | Restricted Stock Unit | 4650 | $0.00 | 4,650.0000 | 14,721,000 | 9999.99% | 0.03% |
| March 17, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 3637 | $0.00 | 7,275.0000 | 14,721,000 | 33.33% | 0.02% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 2561 | $0.00 | 18,837.0000 | 14,721,000 | 15.73% | 0.02% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 752 | $16.79 | 18,085.0000 | 14,721,000 | 3.99% | 0.01% |
| March 11, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 2561 | $0.00 | 0.0000 | 14,721,000 | 100.00% | 0.02% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 3296 | $0.00 | 17,235.0000 | 14,721,000 | 23.65% | 0.02% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 959 | $16.62 | 16,276.0000 | 14,721,000 | 5.56% | 0.01% |
| March 10, 2025 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 3296 | $0.00 | 3,295.0000 | 14,721,000 | 50.01% | 0.02% |
| Oct. 1, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 2491 | $0.00 | 14,211.0000 | 14,769,000 | 21.25% | 0.02% |
| Oct. 1, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 732 | $24.27 | 13,479.0000 | 14,769,000 | 5.15% | 0.00% |
| Oct. 1, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 2491 | $0.00 | 0.0000 | 14,769,000 | 100.00% | 0.02% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | A | Restricted Stock Unit | 10912 | $0.00 | 10,912.0000 | 14,656,000 | 9999.99% | 0.07% |
| March 15, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | A | Stock Option (Right to Buy) | 26442 | $0.00 | 26,442.0000 | 14,656,000 | 9999.99% | 0.18% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 3295 | $0.00 | 10,245.0000 | 14,656,000 | 47.41% | 0.02% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 968 | $25.42 | 9,277.0000 | 14,656,000 | 9.45% | 0.01% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 2561 | $0.00 | 11,838.0000 | 14,656,000 | 27.61% | 0.02% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 752 | $25.79 | 11,086.0000 | 14,656,000 | 6.35% | 0.01% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 3295 | $0.00 | 6,591.0000 | 14,656,000 | 33.33% | 0.02% |
| March 11, 2024 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 2561 | $0.00 | 2,561.0000 | 14,656,000 | 50.00% | 0.02% |
| Oct. 1, 2023 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Common Stock | 2491 | $0.00 | 5,784.0000 | 14,787,000 | 75.65% | 0.02% |
| Oct. 1, 2023 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | F | Common Stock | 732 | $18.63 | 5,052.0000 | 14,787,000 | 12.66% | 0.00% |
| Oct. 1, 2023 | Anika Therapeutics, Inc. | $ANIK | Nunes Anne | SVP, Chief Operations Officer | M | Restricted Stock Unit | 2491 | $0.00 | 0.0000 | 14,787,000 | 100.00% | 0.02% |